0001209191-22-016454.txt : 20220304 0001209191-22-016454.hdr.sgml : 20220304 20220304181225 ACCESSION NUMBER: 0001209191-22-016454 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220302 FILED AS OF DATE: 20220304 DATE AS OF CHANGE: 20220304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PALEKAR ROHAN CENTRAL INDEX KEY: 0001423327 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36327 FILM NUMBER: 22715616 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, THIRD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Neoleukin Therapeutics, Inc. CENTRAL INDEX KEY: 0001404644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-732-2133 MAIL ADDRESS: STREET 1: SUITE 360 - 1616 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC DATE OF NAME CHANGE: 20140128 FORMER COMPANY: FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC DATE OF NAME CHANGE: 20070626 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-02 0 0001404644 Neoleukin Therapeutics, Inc. NLTX 0001423327 PALEKAR ROHAN C/O NEOLEUKIN THERAPEUTICS, INC. 188 EAST BLAINE STREET, #450 SEATTLE WA 98102 1 0 0 0 Stock Option (Right to Buy) 2.72 2022-03-02 4 A 0 50000 0.00 A 2032-03-01 Common Stock 50000 50000 D The option vests as to 1/3 of the total shares on each of March 2, 2023, March 2, 2024 and March 2, 2025, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Sean Smith, as Attorney-in-Fact for Rohan Palekar 2022-03-04